Silvia Catricalà
Silvia Catricalà publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research and Chronic Myeloid Leukemia Treatments.
- World rank
- #2,165,675 of 7,710,434 ranked researchers
- Rank in Italy
- #72,014 of 242,206
- Works
- 30
- Citations
- 1.5k
- Citations per work
- 50.2
What does Silvia Catricalà research?
Silvia Catricalà's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1964.4%
- Medicine1964.4%
- Life Sciences618.4%
- Everything else517.2%
- 1Hematology30% of their works
- 2Genetics26% of their works
- 3Molecular Biology12% of their works
- 4Cancer Research7% of their works
- 5Rheumatology4% of their works
- 6Physiology4% of their works
Research topics
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Cancer Genomics and Diagnostics
- Alzheimer's disease research and treatments
- Protein Kinase Regulation and GTPase Signaling
- Kruppel-like factors research
Which keywords describe Silvia Catricalà's research?
The keywords of their largest research topics: Prognostic Factors, JAK2 Mutation, Myelofibrosis, Acute Myeloid Leukemia, AML, BCR-ABL, Imatinib and Chronic Lymphocytic Leukemia.
- Ras Signaling
- Krüppel-like Factors
- Tau Pathology
- Cancer Genomics
- Transcriptional Regulation
- Chronic Lymphocytic Leukemia
- BCR-ABL
- AML
- JAK2 Mutation
- Prognostic Factors
- Myelofibrosis
- Acute Myeloid Leukemia
- Imatinib
- Genomic Aberrations
- Amyloid Hypothesis
- Mutational Signatures
- Cell Growth
- Protein Kinases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prognostic Factors172 topics
- JAK2 Mutation141 topic
- Myelofibrosis141 topic
- AML131 topic
- Acute Myeloid Leukemia131 topic
- BCR-ABL81 topic
- Imatinib81 topic
- Chronic Lymphocytic Leukemia41 topic
- Genomic Aberrations41 topic
- Transcriptional Regulation42 topics
- Amyloid Hypothesis31 topic
- Cancer Genomics31 topic
- Mutational Signatures31 topic
- Tau Pathology31 topic
- Cell Growth21 topic
- Krüppel-like Factors21 topic
- Protein Kinases21 topic
- Ras Signaling21 topic
Where does Silvia Catricalà work?
Silvia Catricalà's main affiliation in the publication record is University of Pavia, Italy.
How many publications and citations does Silvia Catricalà have?
OpenAlex counts 30 works and 1,507 citations for Silvia Catricalà, an h-index of 9, ranking #2,165,675 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Silvia Catricalà. Posts are plain text and can be reported.